Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
Follow MDLN
Alert me
Medline Inc. (MDLN) EV/Sales
As of 5 November 2026, Medline Inc. (MDLN) trades at a EV/Sales of 1.5×. Over the past ten years it has ranged from 0.0× (March 2026) to 1.7× (April 2026); the current reading is higher than 77% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 1.3× | (10.66%) |
| Jun 2026 | 1.5× | (9.86%) |
| Mar 2026 | 1.6× | — |
| Dec 2025 | 0.0× | — |
| 2 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDLN Medline Inc. | 1.5× |
| BAX Baxter International Inc. compare | 1.7× |
| SOLV Solventum Corporation compare | 2.4× |
| BDX Becton, Dickinson and Company compare | 3.4× |
| COO The Cooper Companies, Inc. compare | 3.5× |
| ALC Alcon compare | 3.7× |
| RMD ResMed Inc. compare | 5.8× |
| WST West Pharmaceutical Services, Inc. compare | 8.1× |
| ISRG Intuitive Surgical, Inc. compare | 13.7× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on MDLN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Book value per share
- The full statement